Join KBI Biopharma, Inc. at CPhI Worldwide this November! Be sure to meet with our expert team, including Mark W. Womack (CEO), Michael Landau (COO), Roland Hecht (SVP, Business Development: Europe & APAC), Toshihiro Ogawa (Sr. Director, Business Development: KBI Asia Region), and Sonja Delalu (Director, Business Development: Selexis).
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
About the Conference:
The biggest international pharma industry event is back! In 2022, CPhI Worldwide becomes CPHI Frankfurt: an event that will take place in-person and online from the 28th September. This hybrid model will fuse the best elements of our traditional show with interactive online features to help you get the most out of your CPHI experience! This year, our conference sessions will be held online and will be available on-demand. Join online at your leisure and save time onsite for sourcing, meeting new contacts and catching up over coffee!